Susquehanna International Group’s Neurogene NGNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$389K Buy
26,006
+11,601
+81% +$173K ﹤0.01% 4678
2025
Q1
$169K Sell
14,405
-60,373
-81% -$707K ﹤0.01% 5609
2024
Q4
$1.71M Buy
74,778
+34,538
+86% +$790K ﹤0.01% 2192
2024
Q3
$1.69M Sell
40,240
-525
-1% -$22K ﹤0.01% 2041
2024
Q2
$1.48M Sell
40,765
-90,493
-69% -$3.29M ﹤0.01% 2089
2024
Q1
$6.68M Buy
+131,258
New +$6.68M ﹤0.01% 858
2023
Q4
Sell
-3,289
Closed -$52K 6403
2023
Q3
$52K Buy
+3,289
New +$52K ﹤0.01% 5107
2023
Q2
Hold
0
6205
2023
Q1
Sell
-1,328
Closed -$13.5K 6462
2022
Q4
$13.5K Buy
+1,328
New +$13.5K ﹤0.01% 5430
2022
Q3
Sell
-3,586
Closed -$74K 6637
2022
Q2
$74K Buy
+3,586
New +$74K ﹤0.01% 5125
2022
Q1
Sell
-1,493
Closed -$144K 6263
2021
Q4
$144K Buy
1,493
+126
+9% +$12.2K ﹤0.01% 5151
2021
Q3
$198K Sell
1,367
-734
-35% -$106K ﹤0.01% 4714
2021
Q2
$388K Buy
2,101
+1,180
+128% +$218K ﹤0.01% 4187
2021
Q1
$227K Buy
921
+415
+82% +$102K ﹤0.01% 4652
2020
Q4
$143K Sell
506
-140
-22% -$39.6K ﹤0.01% 4387
2020
Q3
$155K Buy
+646
New +$155K ﹤0.01% 3980
2020
Q2
Hold
0
4686
2020
Q1
Hold
0
4889
2019
Q4
Hold
0
4539
2018
Q3
Sell
-2,515
Closed -$133K 4231
2018
Q2
$133K Sell
2,515
-1,307
-34% -$69.1K ﹤0.01% 3233
2018
Q1
$1.08M Buy
3,822
+1,739
+83% +$490K ﹤0.01% 1420
2017
Q4
$490K Buy
2,083
+1,454
+231% +$342K ﹤0.01% 2414
2017
Q3
$178K Buy
+629
New +$178K ﹤0.01% 2786
2017
Q2
Hold
0
4065
2017
Q1
Hold
0
4008
2016
Q4
Hold
0
4550
2016
Q3
Sell
-1,192
Closed -$157K 3605
2016
Q2
$157K Buy
+1,192
New +$157K ﹤0.01% 2816